KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Haleon 111.53 Bn 109.67 Bn - -
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn 9.86%
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn -18.92%
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn 2.82%
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn -
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn 45.60%
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn - -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn 39.19%
9 HUTCHMED (China) 10.36 Bn 9.02 Bn - -
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn -82.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.86%
Dec 31, 2025 6.93%
Sep 30, 2025 -17.90%
Jun 30, 2025 226.33%
Mar 31, 2025 -4.04%
Dec 31, 2024 13.75%
Sep 30, 2024 12.48%
Jun 30, 2024 -61.48%
Mar 31, 2024 23.55%
Dec 31, 2023 90.11%
Sep 30, 2023 -42.24%
Jun 30, 2023 13.02%
Mar 31, 2023 -53.33%
Dec 31, 2022 25.64%
Sep 30, 2022 39.23%
Jun 30, 2022 77.23%
Mar 31, 2022 -151.17%
Dec 31, 2021 25.31%
Sep 30, 2021 10.74%
Jun 30, 2021 59.25%
Mar 31, 2021 -34.19%
Dec 31, 2020 -36.03%
Sep 30, 2020 -34.48%
Jun 30, 2020 -16.28%
Mar 31, 2020 67.29%
Dec 31, 2019 125.87%
Sep 30, 2019 -54.73%
Jun 30, 2019 -31.96%
Mar 31, 2019 -26.17%
Dec 31, 2018 -21.55%
Sep 30, 2018 -39.33%
Jun 30, 2018 -74.92%
Mar 31, 2018 -4.68%
Dec 31, 2017 45.05%
Sep 30, 2017 -29.10%
Jun 30, 2017 -42.07%
Mar 31, 2017 -27.21%
Dec 31, 2016 63.86%
Sep 30, 2016 35.77%
Jun 30, 2016 1.14%
Mar 31, 2016 4.26%
Dec 31, 2015 45.01%
Sep 30, 2015 -0.88%
Jun 30, 2015 4.50%
Mar 31, 2015 14.32%
Dec 31, 2014 36.39%
Sep 30, 2014 29.23%
Jun 30, 2014 -7.04%
Mar 31, 2014 -0.32%
Dec 31, 2013 -123.04%
Sep 30, 2013 -21.12%
Jun 30, 2013 0.30%
Mar 31, 2013 9.13%
Dec 31, 2012 -4.16%
Sep 30, 2012 2.03%
Jun 30, 2012 21.33%
Mar 31, 2012 4.87%